Abstract
Purpose
The purpose of this study was to evaluate acupuncture use among breast cancer survivors, including perceived symptom improvements and referral patterns.
Methods
Breast cancer survivors who had used acupuncture for cancer- or treatment-related symptoms were identified using an ongoing prospective Mayo Clinic Breast Disease Registry (MCBDR). Additionally, Mayo Clinic electronic health records (MCEHR) were queried to identify eligible participants. All received a mailed consent form and survey including acupuncture-related questions about acupuncture referrals, delivery, and costs. Respondents were also asked to recall symptom severity before and after acupuncture treatment and time to benefit on Likert scales.
Results
Acupuncture use was reported among 415 participants (12.3%) of the MCBDR. Among MCBDR and MCEHR eligible participants, 241 women returned surveys. A total of 193 (82.1%) participants reported a symptomatic benefit from acupuncture, and 57 (24.1% of participants) reported a “substantial benefit” or “totally resolved my symptoms” (corresponding to 4 and 5 on the 5-point Likert scale). The mean symptom severity decreased by at least 1 point of the 5-point scale for each symptom; the percentage of patients who reported an improvement in symptoms ranged from 56% (lymphedema) to 79% (headache). The majority of patients reported time to benefit as “immediate” (34%) or “after a few treatments” (40.4%). Over half of the participants self-referred for treatment; 24.1% were referred by their oncologist. Acupuncture delivery was more frequent in private offices (61.0%) than in hospital or medical settings (42.3%). Twelve participants (5.1%) reported negative side effects, such as discomfort.
Conclusions
Acupuncture is commonly utilized by patients for a variety of breast cancer–related symptoms. However, patients frequently self-refer for acupuncture treatments, and most acupuncture care is completed at private offices, rather than medical clinic or hospital settings.
Similar content being viewed by others
References
Hershman DL, Unger JM, Greenlee H, Capodice J, Lew DL, Darke A, Kengla A, Melnik MK, Jorgensen CW, Kreisle WH, Minasian LM, Fisch MJ, Henry NL, Crew KD (2017) Randomized blinded sham- and waitlist-controlled trial of acupuncture for joint symptoms related to aromatase inhibitors in women with early stage breast cancer (SWOG 1200). Oral Presentation at: San Antonio Breast Cancer Symposium
Kim KH, Kang KW, Kim DI, Kim HJ, Yoon HM, Lee JM, Jeong JC, Lee MS, Jung HJ, Choi SM (2010) Effects of acupuncture on hot flashes in perimenopausal and postmenopausal women--a multicenter randomized clinical trial. Menopause (New York, NY) 17(2):269–280. https://doi.org/10.1097/gme.0b013e3181bfac3b
Lesi G, Razzini G, Musti MA, Stivanello E, Petrucci C, Benedetti B, Rondini E, Ligabue MB, Scaltriti L, Botti A, Artioli F, Mancuso P, Cardini F, Pandolfi P (2016) Acupuncture as an integrative approach for the treatment of hot flashes in women with breast cancer: a prospective multicenter randomized controlled trial (AcCliMaT). J Clin Oncol 34(15):1795–1802. https://doi.org/10.1200/jco.2015.63.2893
Zhang Y, Lin L, Li H, Hu Y, Tian L (2018) Effects of acupuncture on cancer-related fatigue: a meta-analysis. Support Care Cancer 26(2):415–425. https://doi.org/10.1007/s00520-017-3955-6
Schroeder S, Meyer-Hamme G, Epplee S (2012) Acupuncture for chemotherapy-induced peripheral neuropathy (CIPN): a pilot study using neurography. Acupunct Med 30(1):4–7. https://doi.org/10.1136/acupmed-2011-010034
Bao T, Goloubeva O, Pelser C, Porter N, Primrose J, Hester L, Sadowska M, Lapidus R, Medeiros M, Lao L, Dorsey SG, Badros AZ (2014) A pilot study of acupuncture in treating bortezomib-induced peripheral neuropathy in patients with multiple myeloma. Integr Cancer Ther 13(5):396–404. https://doi.org/10.1177/1534735414534729
Garcia MK, Cohen L, Guo Y, Zhou Y, You B, Chiang J, Orlowski RZ, Weber D, Shah J, Alexanian R, Thomas S, Romaguera J, Zhang L, Badillo M, Chen Y, Wei Q, Lee R, Delasalle K, Green V, Wang M (2014) Electroacupuncture for thalidomide/bortezomib-induced peripheral neuropathy in multiple myeloma: a feasibility study. J Hematol Oncol 7:41. https://doi.org/10.1186/1756-8722-7-41
Zia FZ, Olaku O, Bao T, Berger A, Deng G, Fan AY, Garcia MK, Herman PM, Kaptchuk TJ, Ladas EJ, Langevin HM, Lao L, Lu W, Napadow V, Niemtzow RC, Vickers AJ, Shelley Wang X, Witt CM, Mao JJ (2017) The National Cancer Institute’s Conference on acupuncture for symptom management in oncology: state of the science, evidence, and research gaps. J Natl Cancer Inst Monogr 2017(52). https://doi.org/10.1093/jncimonographs/lgx005
Mao JJ, Palmer CS, Healy KE, Desai K, Amsterdam J (2011) Complementary and alternative medicine use among cancer survivors: a population-based study. J Cancer Surviv 5(1):8–17. https://doi.org/10.1007/s11764-010-0153-7
Enblom A (2017) Patients— and physiotherapists— belief in and use of acupuncture for cancer-related symptoms. Acupunct Med 35(4):251–258. https://doi.org/10.1136/acupmed-2015-011007
Tilburt JC, Miller FG, Jenkins S, Kaptchuk TJ, Clarridge B, Bolcic-Jankovic D, Emanuel EJ, Curlin FA (2010) Factors that influence practitioners' interpretations of evidence from alternative medicine trials: a factorial vignette experiment embedded in a national survey. Med Care 48(4):341–348
Acknowledgments
We would like to thank the study participants for their time as well as Melinda Cooper, Tricia Harstad, and Sebastian Armasu for their assistance with data collection.
Funding
This study was supported by Tracy Starr Breast Cancer Research Fund Award (PI: Ruddy). JZ was supported by Mayo Clinic Medical Scientist Training Program (National Institutes of Health, T32 GM065841).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
CLL has a consulting/advisory role with Pled Pharma, Disarm Therapeutics, Metys, and Asahi Kasei. KRJ inherited and then sold Merck and Pfizer stock in February 2018.
Research involving human participants and/or animals
This study was approved by Mayo Clinic Institutional Review Board (IRB) (IRB nos 181504 and 18006395) in accordance with ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zayas, J., Ruddy, K.J., Olson, J.E. et al. Real-world experiences with acupuncture among breast cancer survivors: a cross-sectional survey study. Support Care Cancer 28, 5833–5838 (2020). https://doi.org/10.1007/s00520-020-05442-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-020-05442-9